1Department of Obstetrics and Gynecology, Rosemary’s Hospital, Daegu, Korea
2Department of Obstetrics and Gynecology, Kyungpook National University Hospital, Daegu, Korea
3Department of Occupational and Environmental Medicine, Yeungnam University Hospital, Daegu, Korea
4Department of Prevention Medicine and Public Health, Yeungnam University College of Medicine, Daegu, Korea
Copyright © 2023 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Conflicts of interest
Joon Sakong has been an editorial board member of Journal of Yeungnam Medical Science since 2004. He was not involved in the review process of this manuscript. There is no conflict of interest to declare.
Funding
None.
Author contributions
Conceptualization: HC, HSK, JS; Investigation: HC; Data curation: HC, HSK; Formal analysis, Supervision: HSK, JS; Methodology, Validation: JS; Writing-original draft: HC; Writing-review & editing: HSK.
Involved organ system | Total |
Maternal age (yr) |
p-value |
Maternal parity |
p-value |
Fetal sex |
p-value | |||
---|---|---|---|---|---|---|---|---|---|---|
≤35 | >35 | Nulli | Multi | Male | Female | |||||
CNS anomaly | 17 (12.4) | 14 (12.4) | 3 (12.5) | >0.999 | 12 (14.0) | 5 (9.8) | 0.476 | 11 (13.1) | 6 (11.3) | 0.759 |
Face anomaly | 9 (6.6) | 6 (5.3) | 3 (12.5) | 0.193 | 6 (7.0) | 3 (5.9) | >0.999 | 6 (7.1) | 3 (5.7) | >0.999 |
Cardiac anomaly | 26 (19.0) | 21 (18.6) | 5 (20.8) | 0.779 | 17 (19.8) | 9 (17.6) | 0.760 | 15 (17.9) | 11 (20.8) | 0.674 |
Pulmonary anomaly | 14 (10.2) | 13 (11.5) | 1 (4.2) | 0.463 | 5 (5.8) | 9 (17.6) | 0.027*,a) | 7 (8.3) | 7 (13.2) | 0.359 |
Gastrointestinal anomaly | 5 (3.6) | 5 (4.4) | 0 (0) | 0.586 | 3 (3.5) | 2 (3.9) | >0.999 | 3 (3.6) | 2 (3.8) | >0.999 |
Genitourinary anomaly | 17 (12.4) | 14 (12.4) | 3 (12.5) | >0.999 | 8 (9.3) | 9 (17.6) | 0.152 | 11 (13.1) | 6 (11.3) | 0.759 |
Musculoskeletal anomaly | 25 (18.2) | 19 (16.8) | 6 (25.0) | 0.385 | 18 (20.9) | 7 (13.7) | 0.291 | 15 (17.9) | 10 (18.9) | 0.881 |
Skin and soft tissue anomaly | 4 (2.9) | 4 (3.5) | 0 (0) | >0.999 | 3 (3.5) | 1 (2.0) | >0.999 | 1 (1.2) | 3 (5.7) | 0.298 |
Multiple anomalies | 10 (7.3) | 8 (7.1) | 2 (8.3) | 0.688 | 9 (10.5) | 1 (2.0) | 0.090 | 8 (9.5) | 2 (3.8) | 0.316 |
Other anomalies | 10 (7.3) | 9 (8.0) | 1 (4.2) | >0.999 | 5 (5.8) | 5 (9.8) | 0.500 | 7 (8.3) | 3 (5.7) | 0.740 |
Characteristic | Male | p-value (OR, 95% CI) | Female | p-value (OR, 95% CI) | Total | p-value (OR, 95% CI) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Normal | Anomaly | Total | Normal | Anomaly | Total | Normal | Anomaly | Total | ||||
Fetal sex | - | - | ||||||||||
Male | 4,127 | 84 (2.0) | 4,211 | 0.023* (1.49, 1.05–2.11) | ||||||||
Female | 3,883 | 53 (1.3) | 3,936 | |||||||||
Age (yr) | 0.807 (0.92, 0.49–1.75) | 0.024* (2.04, 1.09–3.84) | ||||||||||
≤35 | 3,548 | 73 (2.0) | 3,621 | 3,350 | 40 (1.2) | 3,390 | 6,898 | 113 (1.6) | 7,011 | 0.223 (1.32, 0.84–2.06) | ||
>35 | 579 | 11 (1.9) | 590 | 533 | 13 (2.4) | 546 | 1,112 | 24 (2.1) | 1,136 | |||
Parity | 0.041* (0.62, 0.39–0.99) | 0.411 (1.26, 0.73–2.16) | ||||||||||
Nulliparity | 2,391 | 58 (2.4) | 2,449 | 2,269 | 28(1.2) | 2,297 | 4,660 | 86 (1.8) | 4,746 | 0.279 (083, 0.58–1.17) | ||
Multiparity | 1,736 | 26 (1.5) | 1,762 | 1,614 | 25 (1.5) | 1,639 | 3,350 | 51 (1.5) | 3,401 | |||
Race | 0.233 (2.26, 0.54–9.49) | >0.999 | ||||||||||
Korean | 4,083 | 82 (2.0) | 4,165 | 3,832 | 53 (1.4) | 3,885 | 7,915 | 135 (1.7) | 8,050 | 0.679 (1.23, 0.30–5.06) | ||
Foreigner | 44 | 2 (4.3) | 46 | 51 | 0 (0) | 51 | 95 | 2 (2.1) | 97 | |||
Residential locality | 0.268 (1.36, 0.79–2.32) | 0.817 (1.09, 0.53–2.24) | ||||||||||
Daegu | 3,476 | 67 (1.9) | 3,543 | 3,269 | 44 (1.3) | 3,313 | 6,745 | 111 (1.6) | 6,856 | 0.311 (1.25, 0.81–1.92) | ||
Others | 651 | 17 (2.5) | 668 | 614 | 9 (1.4) | 623 | 1,265 | 26 (2.0) | 1,291 | |||
No. of fetuses | 0.018* (3.13, 1.33–7.35) | 0.674 (1.26, 0.30–5.25) | ||||||||||
Singleton | 4,028 | 78 (1.9) | 4,106 | 3,766 | 51 (1.3) | 3,817 | 7,794 | 129 (1.6) | 7,923 | 0.056 (2.24, 1.08–4.63) | ||
Twin | 99 | 6 (5.7) | 105 | 117 | 2 (1.7) | 119 | 216 | 8 (3.6) | 224 |
Involved organ system | Total | Maternal age (yr) |
p-value | Maternal parity |
p-value | Fetal sex |
p-value | |||
---|---|---|---|---|---|---|---|---|---|---|
≤35 | >35 | Nulli | Multi | Male | Female | |||||
CNS anomaly | 17 (12.4) | 14 (12.4) | 3 (12.5) | >0.999 | 12 (14.0) | 5 (9.8) | 0.476 | 11 (13.1) | 6 (11.3) | 0.759 |
Face anomaly | 9 (6.6) | 6 (5.3) | 3 (12.5) | 0.193 | 6 (7.0) | 3 (5.9) | >0.999 | 6 (7.1) | 3 (5.7) | >0.999 |
Cardiac anomaly | 26 (19.0) | 21 (18.6) | 5 (20.8) | 0.779 | 17 (19.8) | 9 (17.6) | 0.760 | 15 (17.9) | 11 (20.8) | 0.674 |
Pulmonary anomaly | 14 (10.2) | 13 (11.5) | 1 (4.2) | 0.463 | 5 (5.8) | 9 (17.6) | 0.027 |
7 (8.3) | 7 (13.2) | 0.359 |
Gastrointestinal anomaly | 5 (3.6) | 5 (4.4) | 0 (0) | 0.586 | 3 (3.5) | 2 (3.9) | >0.999 | 3 (3.6) | 2 (3.8) | >0.999 |
Genitourinary anomaly | 17 (12.4) | 14 (12.4) | 3 (12.5) | >0.999 | 8 (9.3) | 9 (17.6) | 0.152 | 11 (13.1) | 6 (11.3) | 0.759 |
Musculoskeletal anomaly | 25 (18.2) | 19 (16.8) | 6 (25.0) | 0.385 | 18 (20.9) | 7 (13.7) | 0.291 | 15 (17.9) | 10 (18.9) | 0.881 |
Skin and soft tissue anomaly | 4 (2.9) | 4 (3.5) | 0 (0) | >0.999 | 3 (3.5) | 1 (2.0) | >0.999 | 1 (1.2) | 3 (5.7) | 0.298 |
Multiple anomalies | 10 (7.3) | 8 (7.1) | 2 (8.3) | 0.688 | 9 (10.5) | 1 (2.0) | 0.090 | 8 (9.5) | 2 (3.8) | 0.316 |
Other anomalies | 10 (7.3) | 9 (8.0) | 1 (4.2) | >0.999 | 5 (5.8) | 5 (9.8) | 0.500 | 7 (8.3) | 3 (5.7) | 0.740 |
Anomaly | Clinical course |
Total | ||||
---|---|---|---|---|---|---|
Termination | Normal on postpartum FU | Required to FU | Anomaly on postpartum FU | FU loss | ||
CNS anomaly | 4 (23.5) | 5 (29.4) | 1 (5.9) | 1 (5.9) | 6 (35.3) | 17 (100) |
Face anomaly | 4 (44.4) | 0 (0) | 0 (0) | 2 (22.2) | 3 (33.3) | 9 (100) |
Cardiac anomaly | 4 (15.4) | 5 (19.2) | 0 (0) | 13 (50.0) | 4 (15.4) | 26 (100) |
Pulmonary anomaly | 3 (21.4) | 5 (35.7) | 0 (0) | 3 (21.4) | 3 (21.4) | 14 (100) |
Gastrointestinal anomaly | 0 (0) | 1 (20.0) | 0 (0) | 2 (40.0) | 2 (40.0) | 5 (100) |
Genitourinary anomaly | 0 (0) | 4 (23.5) | 4 (23.5) | 9 (52.9) | 0 (0) | 17 (100) |
Musculoskeletal anomaly | 2 (8.0) | 3 (12.0) | 0 (0) | 15 (60.0) | 5 (20.0) | 25 (100) |
Skin and soft tissue anomaly | 0 (0) | 0 (0) | 0 (0) | 2 (50.0) | 2 (50.0) | 4 (100) |
Multiple anomalies | 4 (40.0) | 0 (0) | 0 (0) | 3 (30.0) | 3 (30.0) | 10 (100) |
Other anomalies | 3 (30.0) | 0 (0) | 0 (0) | 3 (30.0) | 4 (40.0) | 10 (100) |
Total | 24 (17.5) | 23 (16.8) | 5 (3.6) | 53 (38.7) | 32 (23.4) | 137 (100) |
Values are presented as number only or number (%) unless otherwise specified. OR, odds ratio; CI, confidence interval. The
Values are presented as number (%). CNS, central nervous system. The Odds ratio, 3.47 (95% confidence interval, 1.09–11.02).
Values are presented as number or number (%). FU, follow-up; CNS, central nervous system.